NCT05868525View on ClinicalTrials.gov

Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA).

PHASE4RecruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

August 23, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Blunt Cerebrovascular Injury
Interventions
DRUG

Aspirin 325Mg Tab, Aspirin 81Mg Tab

Patients will be administrated daily oral Aspirin 81 mg or oral Aspirin 325 mg according to their assigned group after randomization.

Trial Locations (1)

92354

RECRUITING

Loma Linda University Medical Center, Loma Linda

All Listed Sponsors
lead

Loma Linda University

OTHER